Paula Curtis

Rosiglitazone evaluated for cardiovascular outcomes in oral agent combination therapy for type 2 diabetes (RECORD): a multicentre, randomised, open-label trial

Philip Home, Stuart Pocock, Henning Beck‐Nielsen et al. · The Lancet · 2009 · 1.4K citations

Open-label Trial, Diabetes Management, Cardiovascular Disease +10

Rosiglitazone RECORD study: glucose control outcomes at 18 months

Philip Home, Nigel C. Jones, Stuart Pocock et al. · Diabetic Medicine · 2007 · 83 citations · Full text

A double-blind, randomised, parallel group, multinational, multicentre study comparing a single dose of ondansetron 24 mg p.o. with placebo and metoclopramide 10 mg t.d.s. p.o. in the treatment of opioid-induced nausea and emesis in cancer patients

J. Hardy, Susan M. Daly, B. McQuade et al. · Supportive Care in Cancer · 2002 · 75 citations

Pain Medicine, Medicine, Pharmacology +10

Safety and Efficacy of Belimumab in Patients with Lupus Nephritis

Richard Furie, Brad H. Rovin, Frédéric Houssiau et al. · Clinical Journal of the American Society of Nephrology · 2022 · 63 citations · Full text

Effect of the addition of rosiglitazone to metformin or sulfonylureas versus metformin/sulfonylurea combination therapy on ambulatory blood pressure in people with type 2 diabetes: a randomized controlled trial (the RECORD study)

Michel Komajda, Paula Curtis, M Hanefeld et al. · Cardiovascular Diabetology · 2008 · 40 citations · Full text